trending Market Intelligence /marketintelligence/en/news-insights/trending/eois4mi2qle3vybeead79a2 content esgSubNav
In This List

Valeant upsizes loan agreement; to borrow $4.57B

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Valeant upsizes loan agreement; to borrow $4.57B

Valeant Pharmaceuticals International Inc. said it upsized its previously announced refinancing agreement, now looking to borrow $4.57 billion in new term B loans as opposed to $3.82 billion originally.

The Canadian drugmaker added that one of its business units launched an offering of $750 million worth of unsecured senior notes due 2027.

The new loans will be used to refinance Valeant's outstanding term B loans and redeem its senior notes.